SCHEMBL9628191

SCHEMBL9628191

CC1(C)CC(c2ccccn2)c2cc(C(=O)c3cccc(I)c3)ccc2O1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABCC9 O60706 2/20 0.33
PDE4A P27815 1/20 0.33
BRD4 O60885 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TRPV1 Q8NER1 3/20 0.33
ESR1 P03372 1/20 0.32
PABPC1 P11940 1/20 0.32
PLK1 P53350 1/20 0.32
TNKS O95271 3/20 0.32
CTNNB1 P35222 1/20 0.32
WNT3A P56704 1/20 0.32
CYP3A4 P08684 1/20 0.32
VNN1 O95497 1/20 0.31
TGFBR1 P36897 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9628082 0.92 ABCC9 (0.34) ABCC9BRD4SMN1; SMN2TRPV1ESR1
SCHEMBL9527561 0.91 ABCC9 (0.39) ABCC9BRD4SMN1; SMN2KMT2AESR1
SCHEMBL9627698 0.86 BRD4 (0.37) BRD4SMN1; SMN2TRPV1ESR1PABPC1
SCHEMBL9527411 0.84 BRD4 (0.37) BRD4SMN1; SMN2TRPV1CTNNB1WNT3A
SCHEMBL9524902 0.84 ESR1 (0.42) BRD4SMN1; SMN2MEN1KMT2AESR1
SCHEMBL9527983 0.83 TLR3 (0.40) SMN1; SMN2MEN1KMT2ACYP3A4
SCHEMBL9523546 0.83 TGFBR1 (0.39) BRD4SMN1; SMN2MEN1KMT2ATRPV1
SCHEMBL9524954 0.82 BRD4 (0.35) BRD4SMN1; SMN2TRPV1ESR1PABPC1
SCHEMBL9524371 0.82 KDM4E (0.42) BRD4SMN1; SMN2
SCHEMBL9525115 0.79 DRD4 (0.33) ABCC9SMN1; SMN2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5118694-A Hypotensive agents; treatment for cardiovascular and muscular disorders HOFFMANN-LA ROCHE INC. (US) 1992-06-02 US disclosed
US-4971982-A HYPOTENSIVE AGENTS, CARDIOVASCULAR DISORDERS, SMOOTH MUSCLE DISORDERS HOFFMANN-LA ROCHE INC. (US) 1990-11-20 US disclosed